6 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... (LTBI) Pathophysiology ... killed - rest LTBI ... Active TB: • ... Treatment: Active
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... (LTBI) Pathophysiology ... killed - rest LTBI ... Active TB: • ... Treatment: Active
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis ... drug dosing recommendations ... Guidelines for dosing ... #Tuberculosis # ... infections #HIVAIDS #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Individualized Treatment ... Multi-Drug Resistant Tuberculosis ... source cases, the ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics Pharmacology ... Transient K+ efflux moving ... node and AV node activity ... inotropy) ACCP Cardiology ... Antiarrhythmics #Pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
CD4 count <50 cells ... to Table 5 for dosing ... Note: Active TB ... IDSA #Prevention #Treatment ... infections #HIVAIDS #pharmacology